US Patent 10898580 Isoquinolidinobenzodiazepines

Patent 10898580 was granted and assigned to Cellerant Therapeutics on January, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Cellerant Therapeutics

Current Assignee

Cellerant Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

108985800

Patent Inventor Names

Vasu Jammalamadaka0

Jagath R. Junutula0

Date of Patent

January 26, 2021

Patent Application Number

159842810

Date Filed

May 18, 2018

Patent Citations Received

‌

US Patent 11248054 Anti-IL1RAP antibodies and antibody drug conjugates

Patent Primary Examiner

‌

Bruck Kifle

Patent abstract

This disclosure provides novel isoquinolidinobenzodiazepines. These compounds can also be incorporated into antibody-drug conjugates.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10898580 Isoquinolidinobenzodiazepines

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API